Influenza vaccine formulation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 5, 2010
Issued Date -
N/A
app pub date -
Nov 30, 2007
filing date -
Nov 30, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Peptide-based anti-influenza formulations against influenza are disclosed. The peptides are derived from influenza-based epitopes. The formulations are based on peptide mixtures which may be formulated so that variability is present at particular residues. The formulations can be used to prepare vaccines for preventing influenza, particularly avian influenza.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully